Studies of the incidence of sarcomas have been hampered by the use of the classification system ICD (WHO, 1978) (Fraumeni & Boice, 1982; Tucker & Fraumeni, 1982 (Harris et al., 1991) . Final diagnoses were coded using ICD-O (WHO, 1976) Incidence of bone and soft tissue sarcomas overall (including visceral sarcomas) was slightly higher in females than in males but there was no sex difference when non-reviewed cases were taken into account. Incidence of non-visceral tumours was similar in both sexes, but visceral tumours were more common in females, the difference being accounted for mainly by tumours of female genital tract. Bone sarcomas were almost twice as frequent in males as in females.
Distribution by 5-year age band for all cases is shown in Figure 1 . Incidence, in general, increased with increasing age to a peak in the 70-74 year age group. Median age at diagnosis (reviewed cases only) was 61 years for males, 57 years for females and 59.5 years overall. Age distribution for males and females were very similar but with a more sharplydefined and higher peak in incidence for men starting at age 50 years and reaching a maximum at age 70-74 years. In women incidence started to rise steadily from the age of 30 years and continued to a maximum at age 80-84 years. Much of this increased incidence in the middle years from 35-70 is accounted for by the occurrence of tumours found exclusively in women, with 18 out of 20 leiomyosarcomas of the female genital tract and eight out of nine endometrial stromal sarcomas being diagnosed in this age range. In addition to the highest levels of incidence seen in old age there were smaller peaks apparent in both males and females in very young children and in the years covering adolescence and young adulthood. Seven tumours were seen in children aged 0-4 years: three embryonal rhabdomyosarcomas, one embryonal sarcoma, two spindle cell sarcomas and one fibro- sarcoma. In the age range 10-24 years, five of the 36 tumours seen were also rhabdomyosarcomas (one embryonal, and four alveolar) but the peak at this age was almost entirely accounted for by bone tumours: 14 osteosarcomas, one chondrosarcoma and five Ewing's tumours.
Separate distributions for soft tissue sarcomas (excluding those of female genital tract) and bone sarcomas are shown Age distributions for the two commonest bone tumours, osteosarcoma and chondrosarcoma are shown in Figures 6 and 7. From these it can be seen that the bi-modal distribution in incidence of bone tumours described earlier was accounted for by the pattern in diagnosis of osteosarcoma which peaked in the 15-19 age group and again in old age. Incidence of chondrosarcoma was almost constant over the age range 5-59 years except for a small increase at age [35] [36] [37] [38] [39] years, but started to rise at 60 years peaking in the 70-74 year age group. Both osteosarcoma and chondrosar-coma were more common in males than in females and this difference was particularly striking for osteosarcoma in males aged 60 years and over. Median age at diagnosis for reviewed cases with a final diagnosis of osteosarcoma was 18 years (males 20 years, females 17 years) and for chondrosarcoma was 63 years in both sexes. Because, however, the diagnosis of osteosarcoma was made on clinical grounds only in nine out of the 40 cases included in the study, the inclusion of these latter cases, seven of which occurred in individuals over 65 years of age, results in a much higher median age at diagnosis in osteosarcoma overall i.e. 29 years (males 32 years, females 17 years).
Liposarcoma was not seen under 33 years and was more common in females than in males up to age 60 years. Median age at diagnosis was 59 years. Median age at diagnosis for the 12 cases of malignant peripheral nerve sheath tumour was 46.5 years. Two of these latter individuals were stated to have neurofibromatosis and there were indications from the cancer registration forms and pathology reports that a further 2 cases may have been similarly affected.
Rhabdomyosarcoma, specifically the embryonal and alveolar variants, occurred mainly in chidren and young adults. The two cases of pleomorphic sub-type were diagnosed in men aged 62 and 72 years. Distribution of Ewing's tumour paralleled that of osteosarcoma in young people in that seven of the nine cases occurred in individuals aged 10-25 years. Two further cases were seen at ages 43 and 46 years.
In 35 cases, although material was reviewed, no specific type of sarcoma could be specified. These cases were spread bone. M reviewed; = not reviewed. (Harris et al., 1991) . Reclassification of sarcomas in this manner appears to be a common feature of other reviewed series (Presant et al., 1986; Alvegard & Berg, 1989) .
No direct comparisons of these incidence figures with other series are possible as no other centralised peer review of a complete population-based series of sarcomas has been published. Reliable data on childhood sarcomas, however, has been accrued by the Manchester Children's Tumour Registry for more than 30 years (Parkin et al., 1988; Birch et al., 1990) and similar data are now becoming available for other regions (Craft et al., 1987) . Data relating to childhood sarcomas in the North West are likely to be more accurate and complete than those for adult patients. Childhood sarcomas are ascertained directly from histopathologists, paediatricians, surgeons, radiotherapists and haematologists, and cross-checked with regional cancer registrations and with death certificates. Histopathology is subsequently centrally reviewed. Ascertainment of adult cancers, as described previously, is improved by the use of peripatetic clerks who obtain information direct from hospital departments, but some patients are treated in private hospitals some of which do not register cases, and information is also more difficult to obtain on individuals who are treated as outpatients. There is no centralised pathology review.
The two main prerequisites for the production of reliable incidence data on sarcomas are that there should be complete ascertainment of cases derived from a clearly-defined geographical area with a known population, and that centralised histopathology review by experienced pathologists should take place. Since material was obtained and reviewed for 96% of the registered cases entered in the study for whom previous histopathological diagnosis had been recorded, the second requirement was felt to have been adequately fulfilled by the study. Ascertainment of sarcomas in adult patients, however, was entirely dependent on the efficacy of the regional cancer registry. Completeness of cancer registration in the North Western Region was assessed in 1981/1982 at 95% for cases with anniversary year 1974-77, although completeness varied by site of cancer and source of data (Nwene & Smith, 1982) . No assessment of registration of sarcomas has ever been made but in view of the quite high mortality of patients with these tumours there is no reason to assume a registration level below this figure.
The accuracy of the incidence data, however, are subject to two potential drawbacks in that the time period of 3 years which was studied was very short in terms of registration of rare tumours, and that the starting point for the study was those cases specifically registered as sarcomas with the regional registry or where sarcoma was mentioned as a possible diagnosis on the registration form.
Some histological sub-types of sarcomas are so rarely encountered that none would be seen during the 3-year period. Hence no incidence figures can be estimated. Other rare variants which do happen by chance to have been diagnosed in the study period may have been given an incidence figure which was higher than the true frequency of the tumour. Another possible effect of this rarity of sub-type would be to underestimate the age range over which the tumour occurred, and indeed information from the childhood data referred to previously confirms that some of the rare sub-types do occur in children under 15 years of age.
A total of 59,784 tumours was registered with the North Western Regional Cancer Registry during the 3 years of the study, the vast majority of which were carcinomas. No estimate of the number of these which were mis-diagnosed can be made and it is, of course, possible that a certain proportion could have been sarcomas and these cases would have compensated for those which were diagnosed as nonsarcomas in this study. However, a peer review of 3,000 consecutive surgical pathology cases reported by Whitehead et al. (1984) resulted in changes regarded as significant in only 29 (0.96%) cases. None of these were finally diagnosed as sarcomas so it seems unlikely that any significant changes to the incidence figures reported here would be made as a result of central review of all specimens.
Data on bone sarcomas is probably less accurate than that on soft tissue sarcomas as the bone tumours formed only 22% (75/348) of the total sample and of these almost 24% (18/75) could not be reviewed, the majority of these because diagnosis was based upon clinical criteria only. Nevertheless the overall age-specific incidence rates for the three commonest bone tumours, osteosarcoma, chondrosarcoma and Ewing's tumour are essentially similar to those reported by the Third National Cancer Survey which did specify sub-type and covered about 10% of the population of the United States for the years 1969-71 (Cutler & Young, 1975; Fraumeni & Boice, 1982) .
Taking into consideration all the factors relating to ascertainment and their effects on estimates of incidence rates, it is felt that the rates presented in this paper are a reasonably accurate representation of the frequency of occurrence of at least the commoner types of sarcomas seen in the North West Region over the period 1982-84. Comparisons with other series must, however, be made with caution because of changes in diagnostic nomenclature which may occur, better diagnostic accuracy as a result of the use of special stains and the continued specification of new histological sub-types.
